安徽医药最新文献

筛选

英文中文

General anesthesia in patient with Brain Injury 脑损伤患者的全身麻醉

Anhui Medical and Pharmaceutical Journal Pub Date : 2022-01-01 DOI: 10.55940/medphar20224

Ali Anwar Alkuraishy

{"title":"General anesthesia in patient with Brain Injury","authors":"Ali Anwar Alkuraishy","doi":"10.55940/medphar20224","DOIUrl":"https://doi.org/10.55940/medphar20224","url":null,"abstract":"The basic concept of Neuroanesthesia & Neuro Critical Care is referred to as the ABCDE of neuroanesthesia. Early Brain Injury (EBI) was formerly known as primary brain injury. In EBI there is a loss of autoregulation and loss of blood-brain barrier integrity. The presence of Cushing's triad indicates the presence of intracranial hypertension. The target of blood pressure in traumatic brain injury (TBI) is to avoid blood pressure systolic <110 mmHg, maintain cerebral perfusion pressure (CPP) 60-70 mmHg, target PaCO2 regulation is normocarbia, PaCO2 35–40 mmHg, prophylactic use of phenytoin or valproate is not recommended to prevent late post-traumatic seizures (late PTS). There is still a need to analyse decompressive craniectomy (DECRA) therapy compared with continued medical therapy for refractory intracranial pressure (ICP) elevations after TBI. General anesthesia for patients with severe TBI is preferable to total intravenous anesthesia (TIVA), the administration of fluids should consider the osmolarity of these fluids. In the new concept, in patients with elevated ICP, the volatile anesthetic concentration should be limited to 0.5 MAC. The target blood sugar is normoglycemia. Prophylactic or therapeutic hypothermia appears to have no place in the management of severe brain injury","PeriodicalId":7822,"journal":{"name":"Anhui Medical and Pharmaceutical Journal","volume":"185 2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77345275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 9

Neurodevelopmental Abnormalities in Children Associated with Maternal Use of Psychoactive Medication 与母亲使用精神活性药物相关的儿童神经发育异常

Anhui Medical and Pharmaceutical Journal Pub Date : 2022-01-01 DOI: 10.55940/medphar202210

Karam T Tawfeek, Ghufran Z. Zuhair, Hany A. Al-hussaniy, M. Naji

{"title":"Neurodevelopmental Abnormalities in Children Associated with Maternal Use of Psychoactive Medication","authors":"Karam T Tawfeek, Ghufran Z. Zuhair, Hany A. Al-hussaniy, M. Naji","doi":"10.55940/medphar202210","DOIUrl":"https://doi.org/10.55940/medphar202210","url":null,"abstract":"Background: Due to its negative effects on the unborn child and the mother as a consumer, pregnant women's intake of psychoactive substances has become a public health concern. Additionally, consuming these chemicals has been linked to several neurological development changes in children, including behavioral issues (such as attention deficit hyperactivity disorder and autism spectrum disorder), cognitive issues, and sensory and motor function changes. Objectives: To perform a thorough, comprehensive study of the neurodevelopmental problems in children linked to maternal drug use. Method: A search of the scientific literature on studies about neurodevelopmental abnormalities linked to maternal use of psychoactive medications during pregnancy and published in the previous ten years up to June 2022 was conducted from PubMed, Google Scholar, and Directory open access Journals. Results: The initial screening identified 380 articles. We excluded 50 unaccessible articles and 160 articles due to publication dates and study types; after that, 62 articles were also discarded because they were duplicates, and 68 were excluded because the information was irrelevant or systemic reviews, so we finally obtained 40 articles for full-text reading distributed as follows: 18 from PubMed, 12 from Directory Open Access Journal, and 10 from Google scholar","PeriodicalId":7822,"journal":{"name":"Anhui Medical and Pharmaceutical Journal","volume":"66 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77950683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Cardiopulmonary cerebral resuscitation 心肺脑复苏

Anhui Medical and Pharmaceutical Journal Pub Date : 2010-01-01 DOI: 10.1016/b978-1-4160-3969-3.00254-7

Xu Fei-fan

引用次数: 0

首页上一页